UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice

The Journal of biological chemistry, 2021-01, Vol.296, p.100150-100150, Article 100150

2021

Volltextzugriff (PDF)

Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease

Journal of neurochemistry, 2021-06, Vol.157 (6), p.1897-1910

2021

Volltextzugriff (PDF)

Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency

Brain (London, England : 1878), 2022-07, Vol.145 (7), p.2361-2377

2022

Volltextzugriff (PDF)

Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases

Cell reports (Cambridge), 2019-04, Vol.27 (5), p.1334-1344.e6

2019

Volltextzugriff (PDF)

PTG protein depletion rescues malin-deficient Lafora disease in mouse

Annals of neurology, 2014-03, Vol.75 (3), p.442-446

2014

Volltextzugriff (PDF)

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain

Cell reports (Cambridge), 2024-01, Vol.43 (1), p.113653-113653, Article 113653

2024

Volltextzugriff (PDF)

Inhibiting glycogen synthesis prevents lafora disease in a mouse model

Annals of neurology, 2013-08, Vol.74 (2), p.297-300

2013

Volltextzugriff (PDF)

Adeno-associated virus 2 bound to its cellular receptor AAVR

Nature microbiology, 2019-04, Vol.4 (4), p.675-682

2019

Volltextzugriff (PDF)

Early-onset Lafora body disease

Brain (London, England : 1878), 2012-09, Vol.135 (Pt 9), p.2684-2698

2012

Volltextzugriff (PDF)

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease

EMBO molecular medicine, 2017-07, Vol.9 (7), p.906-917

2017

Volltextzugriff (PDF)

Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease

The Journal of biological chemistry, 2008-12, Vol.283 (49), p.33816-33825

2008

Volltextzugriff (PDF)

PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease

PLoS genetics, 2011-04, Vol.7 (4), p.e1002037-e1002037

2011

Volltextzugriff (PDF)

Retinal Phenotyping of a Murine Model of Lafora Disease

Genes, 2023-03, Vol.14 (4), p.854

2023

Volltextzugriff (PDF)

Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (49), p.19262-19266

2007

Volltextzugriff (PDF)

Experimental study on elemental mercury removal by diperiodatonickelate (IV) solution

Journal of hazardous materials, 2013-09, Vol.260, p.383-388

2013

Volltextzugriff (PDF)

Glycogen hyperphosphorylation underlies lafora body formation

Annals of neurology, 2010-12, Vol.68 (6), p.925-933

2010

Volltextzugriff (PDF)

LGI2 truncation causes a remitting focal epilepsy in dogs

PLoS genetics, 2011-07, Vol.7 (7), p.e1002194-e1002194

2011

Volltextzugriff (PDF)

Mutations in NHLRC1 cause progressive myoclonus epilepsy

Nature genetics, 2003-10, Vol.35 (2), p.125-127

2003

Volltextzugriff (PDF)

GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease

Annals of clinical and translational neurology, 2020-11, Vol.7 (11), p.2186-2198

2020

Volltextzugriff (PDF)

Peroxymonosulfate catalyzed by rGO assisted CoFe2O4 catalyst for removing Hg0 from flue gas in heterogeneous system

Environmental pollution (1987), 2019-06, Vol.249, p.868-877

2019

Volltextzugriff (PDF)

Hydrogenation of carbon dioxide under atmospheric pressure and low temperature

International journal of hydrogen energy, 2018-02, Vol.43 (5), p.3062-3069

2018

Volltextzugriff (PDF)

Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease

Brain (London, England : 1878), 2021-11, Vol.144 (10), p.2985-2993

2021

Volltextzugriff (PDF)

Catalytic reduction of carbon dioxide by nickel-based catalyst under atmospheric pressure

Chemical engineering journal (Lausanne, Switzerland : 1996), 2016-08, Vol.297, p.11-18

2016

Volltextzugriff (PDF)

Antisense Oligonucleotide Therapy for Lafora Disease (S53.005)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Ketogenic diet reduces Lafora bodies in murine Lafora disease

Neurology. Genetics, 2020-12, Vol.6 (6), p.e533-e533

2020

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(108)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(66)
Humans
(34)
Technology
(27)
Animals
(22)
Male
(20)
Mice
(20)
Female
(19)
Neurosciences & Neurology
(16)
Engineering
(15)
Neurosciences
(14)
Physical Sciences
(12)
Biochemistry & Molecular Biology
(11)
Materials Science
(11)
Adult
(10)
Clinical Neurology
(10)
Materials Science, Multidisciplinary
(10)
Disease Models, Animal
(9)
Lafora Disease
(9)
Lafora Disease - Genetics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice

Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease

Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency

Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases

PTG protein depletion rescues malin-deficient Lafora disease in mouse

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain

Inhibiting glycogen synthesis prevents lafora disease in a mouse model

Adeno-associated virus 2 bound to its cellular receptor AAVR

Early-onset Lafora body disease

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease

Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease

PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease

Retinal Phenotyping of a Murine Model of Lafora Disease

Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo

Experimental study on elemental mercury removal by diperiodatonickelate (IV) solution

Glycogen hyperphosphorylation underlies lafora body formation

LGI2 truncation causes a remitting focal epilepsy in dogs

Mutations in NHLRC1 cause progressive myoclonus epilepsy

GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease

Peroxymonosulfate catalyzed by rGO assisted CoFe2O4 catalyst for removing Hg0 from flue gas in heterogeneous system

Hydrogenation of carbon dioxide under atmospheric pressure and low temperature

Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease

Catalytic reduction of carbon dioxide by nickel-based catalyst under atmospheric pressure

Antisense Oligonucleotide Therapy for Lafora Disease (S53.005)

Ketogenic diet reduces Lafora bodies in murine Lafora disease

Suchergebnisse filtern